Literature DB >> 22764365

Progressive mental status changes and seizures with fluid attenuated inversion recovery (FLAIR) hyperintensity on brain MRI.

Erick Tarula1, Shakti Ramkissoon, Sean Pittock, Volney L Sheen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22764365      PMCID: PMC3613846     

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


× No keyword cloud information.
  6 in total

1.  F-18 fluorodeoxyglucose PET/CT findings in a case of anti-NMDA receptor encephalitis.

Authors:  Brandt C Mohr; Satoshi Minoshima
Journal:  Clin Nucl Med       Date:  2010-06       Impact factor: 7.794

2.  A modern perspective on the differential diagnosis between encephalitis lethargica or anti-NMDA-receptor encephalitis.

Authors:  Aaron Tan; Neil Shuey; Christopher Bladin
Journal:  J Clin Neurosci       Date:  2010-06-03       Impact factor: 1.961

Review 3.  [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].

Authors:  Takahiro Iizuka; Fumihiko Sakai
Journal:  Brain Nerve       Date:  2008-09

4.  Anti-NMDA receptor encephalitis with atypical brain changes on MRI.

Authors:  Sophelia H S Chan; Virginia C N Wong; Cheuk-wing Fung; Russell C Dale; Angela Vincent
Journal:  Pediatr Neurol       Date:  2010-10       Impact factor: 3.372

5.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

6.  Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis.

Authors:  Sekhar C Pillai; Deepak Gill; Richard Webster; Robert Howman-Giles; Russell C Dale
Journal:  Pediatr Neurol       Date:  2010-09       Impact factor: 3.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.